Study suggests epiregulin as target in lung cancer
Thursday, April 7, 2016 - 12:32
in Health & Medicine
A new potential biomarker and target has been identified in lung cancer, namely epiregulin, an under-studied EGF-like growth factor. This discovery led researchers to question whether this upregulation was happenstance, correlative, or in fact causative in the disease.